Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2016 Apr 18;11(4):e0153653.
doi: 10.1371/journal.pone.0153653. eCollection 2016.

Positive Impact of Nutritional Interventions on Serum Symmetric Dimethylarginine and Creatinine Concentrations in Client-Owned Geriatric Dogs

Affiliations
Randomized Controlled Trial

Positive Impact of Nutritional Interventions on Serum Symmetric Dimethylarginine and Creatinine Concentrations in Client-Owned Geriatric Dogs

Jean A Hall et al. PLoS One. .

Abstract

A prospective study was conducted in client-owned geriatric dogs to evaluate the short-term effects of a test food on serum symmetric dimethylarginine (SDMA) and creatinine (Cr) concentrations. Test food contained functional lipids (fish oil), antioxidants (lipoic acid, vitamins C and E), L-carnitine, botanicals (fruits and vegetables), controlled sodium concentration, and high quality protein sources (high bioavailability and an ideal amino acid composition). Dogs (n = 210) were fed either test food or owner's-choice foods (non-nutritionally controlled cohort). Dogs were included based on age and body weight: small (6.8 to 11.4 kg) and medium dogs (11.5 to 22.7 kg) were ≥ 9 years, whereas dogs >22.7 kg were ≥ 7 years at baseline. At baseline, all dogs had to have serum Cr concentrations within the reference interval and be free of chronic disease. Renal function biomarkers and urinalysis results at baseline, and after consuming test food or owner's-choice foods for 3 and 6 months, were evaluated. Only dogs consuming test food showed significant decreases in serum SDMA and Cr concentrations (both P ≤ 0.05) across time. At baseline or during the 6-month feeding trial, 18 dogs (8.6%) had increased serum SDMA, but normal serum Cr, consistent with IRIS Stage 1 chronic kidney disease. This included 9 dogs fed test food and 9 dogs fed owner's-choice foods. Compared with baseline, after feeding 9 dogs test food for 6 months, serum SDMA decreased in 8 dogs and increased in 1 dog. After feeding 9 dogs owner's-choice foods for 6 months, serum SDMA decreased in 4 dogs and increased in 4 dogs (remained stable in 1 dog). The decreases in serum SDMA and Cr concentrations were significant (both P = 0.03) only for dogs fed test food. These results suggest that nonazotemic dogs with elevated serum SDMA (early renal insufficiency) when fed a test food designed to promote healthy aging are more likely to demonstrate improved renal function compared with dogs fed owner's-choice foods.

PubMed Disclaimer

Conflict of interest statement

Competing Interests: Four of the authors (JM, HS, IPR, and DEJ) have an affiliation to the commercial funders of this research, as employees of Hill's Pet Nutrition, Inc. The work presented in this study was funded by and performed at the Pet Nutrition Center, Hill's Pet Nutrition, Inc., Topeka, KS (http://www.hillspet.com/our-company.html). Three of the authors (Maha Y, EO, and Murthy Y) have an affiliation to a commercial company, as employees of IDEXX Laboratories, Inc., that holds a patent on the ELISA methodology for measuring SDMA concentration (http://www.idexx.com/view/xhtml/en_us/corporate/home.jsf). The patent no. is United States Patent No. US 481,690 B2; Date: July 9, 2013 Murthy et al., Methods for Detecting Symmetrical Dimethylarginine. This does not alter the authors' adherence to PLOS ONE policies on sharing data and materials. Data is freely available upon request. Jean A. Hall has received research grant support from Hill’s Pet nutrition, Inc. in the past.

Similar articles

Cited by

References

    1. Hall JA, Yerramilli M, Obare E, Jewell DE. Comparison of serum concentrations of symmetric dimethylarginine and creatinine as kidney function biomarkers in cats with chronic kidney disease. J Vet Intern Med. 2014;28(6):1676–83. Epub 2014/09/19. 10.1111/jvim.12445 . - DOI - PMC - PubMed
    1. Hall JA, Yerramilli M, Obare E, Yerramilli M, Almes K, Jewell DE. Comparison of serum concentrations of symmetric dimethylarginine and creatinine as kidney function biomarkers in dogs with chronic renal disease. J Vet Intern Med. 2016. - PMC - PubMed
    1. Schwedhelm E, Boger RH. The role of asymmetric and symmetric dimethylarginines in renal disease. Nat Rev Nephrol. 2011;7(5):275–85. Epub 2011/03/30. 10.1038/nrneph.2011.31 [pii]. . - DOI - PubMed
    1. Kielstein JT, Boger RH, Bode-Boger SM, Frolich JC, Haller H, Ritz E, et al. Marked increase of asymmetric dimethylarginine in patients with incipient primary chronic renal disease. J Am Soc Nephrol. 2002;13(1):170–6. Epub 2001/12/26. . - PubMed
    1. Kielstein JT, Salpeter SR, Bode-Boeger SM, Cooke JP, Fliser D. Symmetric dimethylarginine (SDMA) as endogenous marker of renal function—A meta-analysis. Nephrol Dial Transplant. 2006;21(9):2446–51. Epub 2006/06/13. gfl292 [pii] 10.1093/ndt/gfl292 . - DOI - PubMed

Publication types

LinkOut - more resources